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Abstract
We present a comprehensive probabilistic point process framework to estimate and monitor the
instantaneous heartbeat dynamics as related to specific cardiovascular control mechanisms and
hemodynamics. Assessment of the model’s statistics is established through the Wiener-Volterra
theory and a multivariate autoregressive (AR) structure. A variety of instantaneous cardiovascular
metrics, such as heart rate (HR), heart rate variability (HRV), respiratory sinus arrhythmia (RSA),
and baroreceptor-cardiac reflex (BRS), can be rigorously derived within a parametric framework
and instantaneously updated with an adaptive algorithm. Instantaneous metrics of nonlinearity,
such as the bispectrum of heartbeat intervals, can also be derived. We have applied the proposed
point process framework to experimental recordings from healthy subjects in order to monitor
cardiovascular regulation under propofol anesthesia. Results reveal interesting dynamic trends
across different pharmacological interventions, confirming the ability of the algorithm to track
important changes in cardiorespiratory elicited interactions, and pointing at our mathematical
approach as a promising monitoring tool for an accurate, noninvasive assessment of general
anesthesia.
I. INTRODUCTION
In recent years, advanced statistical models have been developed for evaluating the heartbeat
dynamics [1–3]. Heartbeats, once detected from continuous electrocardiogram (ECG) signal,
are treated as discrete events that can be modeled by a stochastic point process [2, 3].
Various probabilistic models (e.g., the inverse Gaussian, Gaussian, lognormal, or gamma
distribution) can be used to model the heartbeat interval [4], whereas its mean is modulated
by previous inter-beat intervals. Nonlinearity of the heartbeat dynamics, as well as the
interactions between the heartbeat and other cardiovascular measures, have always been
subject of important studies in the last decades. In light of the Wiener-Volterra theory, we
present a comprehensive point process framework to include the interactions between the
heartbeat intervals and other cardiovascular measures such as respiration and arterial blood
pressure, as well as assessing nonlinear heartbeat dynamics.
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II. METHODS
A. The Heartbeat Interval Point Process Model
Given a set of R-wave events {uj}j=1J detected from the electrocardiogram (ECG), let RRj =
uj −uj−1 > 0 denote the jth R-R interval. By treating the R-waves as discrete events, we
develop a point process model for the heartbeat interval. Assuming history beat dependence,
the waiting time t − uj (t>uj) until the next R-wave event can be modeled by an inverse
Gaussian model [2]:
(1)
where uj denotes the previous R-wave event occurred before time t, θ > 0 denotes the shape
parameter, and μRR(t) denotes the instantaneous R-R mean. As HR is defined as the
reciprocal of RR. by the change-of-variables formula, the mean and the standard deviation
of HR can be derived [2], as given by μHR = μ̃−1 + θ̃−1 and  where μ̃ =
c−1 μRR, and c = 60 s/min.
B. Modeling the Instantaneous Mean Heartbeat Interval
In general, let us consider a causal, continuous-time nonlinear mapping F between an output
variable y(t) and two input variables x(t) and u(t). Expanding the Wiener-Volterra series of
function F (up to the second order) with respect to inputs x(t) and u(t) yields to a sum of first
and second order convolutions of the inputs with Volterra kernels of appropriate orders [7].
In our model, y(t) will be replaced by μRR(t), x(t) will be replaced by the previous R-R
intervals, u(t) will be replaced by either BP or RESP, or both, and the continuous-time
integral will be approximated by a finite and discrete approximation. Our framework
considers three important cases:
Case 1: Univariate Model. Dropping off the terms that involve all of covariate terms in the
Volterra series expansion, we obtain a discrete-time system:
(2)
where the first two terms represent a linear autoregressive (AR) model of the past R-R
intervals, a0(t) compensates the nonzero mean effect of the R-R measurements, and
Case 2: Multivariate Model. Dropping off the last two quadratic terms in the Volterra series
expansion, we obtain
(3)
which yields a bivariate bilinear system. Here the covariate COV = [BP RESP]
measurements are assumed to have the mean subtracted as for RR in (2) [16].
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Case 3: ARIMA (ARX on the differences) Linear Multivariate Model. We define the
“increment of the R-R series” {δRRt−i} ≡ {RRt−i − RRt−i−1} and the “increment of the
covariate series” {δCOVt−i} ≡ {COVt−i − COVt−i−1}, and model the instantaneous heartbeat
interval mean by
(4)
where ã0 (t) in (3) has been replaced by RRt−1 in (4) [8].
C. Frequency Analysis
From Equation (2), the instantaneous R-R spectrum of the linear part is
(5)
With the time-varying AR coefficients {ai(t)} estimated from the point-process filter, we
may evaluate the spectral power of Eq. (5) at different ranges (LF, 0.04–0.15 Hz; HF, 0.15-
min{0.5,0.5/RR} Hz, where 0.5/RR denotes the Nyquist sampling frequency). Let h(t)
denote a vector that contains all of 2nd-order coefficients {hkl (t)}; in light of (5), we may
compute an instantaneous index that quantifies the fractional contribution between the
cross-spectrum and the cross-bispectrum [6]:
(6)
where |·| denotes either the norm of a vector or the modulus of a complex variable. The “ ≈ ”
is due to a Gaussian assumption used in deriving (6). A small value of ρ implies a presence
of significant (nonzero) values in {hkl} (i.e. nonlinearity), whereas a perfect linear Gaussian
model would imply ρ = 1. (of note, ρ is indicated as rho in figures)
In light of Eq. (3) we can compute the frequency response for the covariate transfer function
(BP→RR or RESP→RR)
(7)
where f1 and f2 denote the rate (beat/s) for the R-R and covariate intervals, respectively; here
we assume f1 ≈ f2 ≡ f (namely, the heartbeat period is about the same as the covariate-event
period). The order of the AR model also determines the number of poles, or oscillations, in
the frequency range. Modifying the AR coefficients is equivalent to changing the positions
of the poles and reshaping the frequency response curve. With the time-varying AR
coefficients {ãi (t)} and {b̃j (t)} estimated from the point-process filter (section D. below),
we may evaluate the dynamic frequency response of Eq. (7) at different ranges (LF, 0.04–
0.15 Hz; HF, 0.15-min{0.5,0.5/RR} Hz, where 0.5/RR denotes the Nyquist sampling
frequency). The frequency-dependent transfer function gain, characterized by |H12(f)|,
represents the effect of the covariate on heartbeat, mediated by the neural autonomic reflex.
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In particular, RSA and BRS (two of the indices shown in figures) are computed from this
gain for RESP and BP respectively. Since the R-R interval is influenced by respiratory input
at the HF range, it is more common and meaningful to examine the baroreflex gain at the LF
range. In light of Eq. (4), we can determine, in the same fashion as (7) and with similar
interpretations [8] the differential transfer function
D. Adaptive Point Process Filtering and Goodness-of-Fit
In order to empower the model in a nonstationary environment, we can recursively estimate
the parameters via adaptive point process filtering at any time resolution. The state-space
formulation of the discrete-time point process filtering algorithm is described in [5,6,7]. The
choice of bin size (Δ) reflects the timescale of estimation interest, we often use Δ=5 ms. The
point process filtering equations can be viewed as a point process analog of the Kalman
filtering equations (for continuous-valued observations). Given a predicted (a priori)
estimate, the innovations are weighted by an ‘adaptation’ gain to further produce the filtered
(a posteriori) estimate. Since the innovations are likely to be nonzero in the absence of a
beat, the parameters are always updated at each time bin. Goodness-of-fit of all models is
evaluated using a Kolmogorov-Smirnov (KS) test based on the time-rescaling theorem, and
the transformed quantiles’ autocorrelation function is further computed to check
independence of the transformed intervals [5,6,7].
E. Experimental Protocol
A total of 15 healthy volunteer subjects (mean age 24 ± 4) gave written consent to
participate in this study approved by the Massachusetts General Hospital (MGH).
Intravenous and arterial lines were placed in each subject. Propofol was infused
intravenously using a previously validated computer-controlled delivery system running
STANPUMP connected to a Harvard 22 syringe pump (Harvard Apparatus, Holliston, MA).
Five effect-site target concentrations (0–4 mcg/ml) were each maintained for 15 minutes
respectively. Capnography, pulse oximetry, ECG, and arterial BP (P1) were recorded
(sampling rate 1 kHz) and monitored continuously by an anesthesiologist throughout the
study. Bagmask ventilation with 30% oxygen was administered as needed in the event of
propofol-induced apnea. Because propofol is a potent peripheral vasodilator, phenylephrine
was administered intravenously to maintain mean arterial BP within 20% of baseline [7].
III. RESULTS
Results on application of our model framework include instantaneous assessment of HRV,
RSA, Baroreflex (BRS), and of nonlinear dynamics in healthy subjects under progressive
stages of anesthesia [4–8]. All instantaneous indices are estimated to accommodate the
nonstationary nature of the experimental recordings. Overall, our observations have revealed
interesting dynamic trends across the experiment. We are here showing two original
examples:
(1) Figure 1 shows a subject transitioning from level 0 to level 3. Clearly, HRV, RSA and
BRS progressively decrease, accompanied by a relevant increase in linear cardiorespiratory
coupling as a result of administration of the first propofol bolus (despite the small scale, note
the two sharp drops in BRS at the level 1→2 and 2→3 transitions). (2) Figure 2 shows a
different subject where, after first propofol administration, phenylephrine is administered to
compensate a critical drop in blood pressure, followed by artificial ventilation. Here, a sharp
decrease in RSA is observed with anesthetic intervention, respiratory coupling is then partly
restored, but blood pressure progressively decreases to critical levels, possibly due to
baroreflex failure. After phenylephrine is administered, baroreflex gain and blood pressure
slightly recover, but fail to go back to baseline levels. Artificial ventilation reflects in RSA
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variability and acts to restore HRV, only partly succeeding in raising blood pressure levels.
Table I further shows a statistical summary of levels 1–5 as compared with baseline,
accompanied by a portrayal of the instantaneous dynamics observed within each level for
the considered indices (Figure 3), confirming the progressive decrease in HRV, RSA and
BRS, as well as the linear cardiorespiratory coupling increase in the first two levels of
anesthesia.
IV. DISCUSSION
In a non-stationary scenario where the physiological state may change dramatically,
dynamic assessment of cardiovascular control during the transient period is of vital
importance. Overall, our observations have revealed important dynamics involved with
induction of anesthesia. The study of the transient periods due to pharmacological and
physical intervention has demonstrated the capacity of the point-process filter to quickly
capture fast physiological changes in the cardiovascular system, for example when
baroreflex responses are supposedly triggered, and consequently accompanied by a
significant drop in the instantaneous baroreflex gain. The clear reduction of BRS with
anesthesia might suggest that baroreflex responses are reset with propofol to control HR at a
lower BP, and that BRS further decreased after administration as a result. The shift in the
HR/BP set point may reflect the propofol’s systemic vasodilatory effect, whereas baroreflex
impairment is most likely the result of disruption of cardiac control within the central
nervous system.
The dynamic estimates further suggest that RSA gradually decreases from baseline after
administration of propofol anesthesia, that RSA is generally suppressed by phenylephrine;
and that the linear interactions within the cardiorespiratory control remain stable or increase
[5]. Specifically, RSA is likely to be mediated by withdrawal of vagal efferent activity
resulting from either baroreflex response to spontaneous BP fluctuations, or respiratory
gating of central arterial baroreceptor and chemoreceptor afferent inputs. Of note, we also
observed an increase of nonlinearity in heartbeat interval dynamics from baseline to
anesthesia, where the nonlinearity involved the bilinear interactions between RR and
systolic blood pressure (SBP) accompanied by a significant decrease in linear coherence
between these two series [7]. This seems to suggest that the nonlinear component of
heartbeat interval dynamics during anesthesia is mainly contributed from the cardiovascular
(baroreflex) loop, whereas the linear interaction within the cardiorespiratory loop roughly
remains unchanged. It is also possible that the respiratory system indirectly influences HR
by modulating the baroreceptor and chemoreceptor input to cardiac vagal neurons. However,
in our experimental condition, it is difficult to validate the separate influence of SBP from
the influence of respiration on HRV.
V. CONCLUSION
A combined point process framework is proposed which enables us to simultaneously assess
the linear and nonlinear indices of HRV, together with important cardiovascular functions of
interest, in clinical recordings during induction of propofol anesthesia. All of these statistical
indices may serve as potential indicators for ambulatory monitoring in clinical practice, and
may particularly provide a valuable quantitative assessment of the interaction between
heartbeat dynamics and hemodynamics during general anesthesia. More importantly, these
quantitative indices could be monitored intraoperatively in order to improve drug
administration and reduce side-effects of anesthetic drugs.
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Figure 1.
Tracking results of various instantaneous indices for Subject 15. Three transient periods
(level 0–>1, level 1–>2, level 2–>3) are shown.
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Figure 2.
Tracking results of various instantaneous indices for Subject 9. The two dashed lines (~
2010 s and ~3000 s) mark the drug concentration level 0–>1, (i.e., propofol administration
onset time) and level 1–>2, respectively. The dotted dashed line (~2960 s) marks the time
when phenylephrine was administered; and the dotted line (~3125 s) marks the time of hand
ventilation.
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Figure 3.
Estimates of the instantaneous indices for six drug concentration levels (0–5) for Subject 9.
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